Results 111 to 120 of about 500,219 (165)

Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL

, 2007
INTRODUCTION: The study was conducted to assess the impact of depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL (DMPA-SC 104) on body weight.
Milsom, Ian,, Ray, A, Jain, J K, Westhoff, C   +3 more
core  

Formative study summary report: Acceptability & feasibility of DMPA-SC self-injection in Punjab, Pakistan

This formative assessment, conducted in 2023, was an exploratory qualitative inquiry designed to understand potential user, service provider and stakeholder perspectives on how to offer, introduce and support the use of DMPA-SC self-injection in ways that meet the needs and interests of women in Punjab, Pakistan.
Qayyum, Kanwal, Tappis, Hannah, Haider, Huma, Christofield, Megan, Ameen, Afshan, Fatima, Aisha, Assad, Fauzia, Hamdani, Insha   +7 more
openaire   +1 more source

HUBUNGAN LAMA PENGGUNAAN KONTRASEPSI DEPO MEDROKSIPROGESTERON ASETAT (DMPA) DENGAN OBESITAS [PDF]

, 2016
Kontrasepsi Depo Medroksiprogesteron Asetat (DMPA) merupakan kontrasepsi injeksi golongan progestin (Progestin Only Injectable Contraceptive) yang mengandung medroksiprogesteron asetat yang diinjeksikan setiap 3 bulan.
Suciana
core  

Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

, 2014
Objectives To evaluate feasibility, acceptability, continuation, and trough serum levels following self-administration of subcutaneous (sc) depot medroxyprogesterone acetate (DMPA).
White, Katharine, MD
core   +1 more source

Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021

Journal of Gynecology and Obstetrics, 2022
Soumah Aboubacar Fode Momo, Moussa Kantara Camara, Ibrahima Koussy Bah, Conte Ibrahima, Sylla Ibrahima   +4 more
openaire   +1 more source

HUBUNGAN LAMANYA PEMAKAIAN KONTRASEPSI SUNTIK DMPA DENGAN KEMBALINYA KESUBURAN PADA POST AKSEPTOR KB SUNTIK DMPA

, 2010
The objective of the research is to know correlation between duration of using injectable depomedroxy progesterone acetate (DMPA) with return of fertility in women ex-user injectable DMPA .The research was conducted in April to August 2010.
Handayani, Rohmi, Suryani, Evi Sri, Fajarsari, Dyah   +2 more
core  

REVOLUTIONIZING CONTRACEPTION: PERCEPTION AND INFLUENCE OF SELF- ADMINISTERED DEPOT MEDROXYPROGESTERONE ACETATE ON CONTRACEPTION PREVALENCE

Background: The self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has emerged as an innovative approach to improve contraceptive access and reproductive autonomy among women.
Sheeraz Shah, Muhammad Ilyas Siddiqui, Rafaina Shah, Maria Saba Shah   +3 more
core   +1 more source

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

, 2006
BACKGROUND: A clinical study compared efficacy and safety of depot medroxyprogesterone acetate (DMPA) with leuprolide for endometriosis-associated pain.
A Ray, A Bergqvist, A Luciano, P G Crosignani   +3 more
core  

Costs of administering injectable contraceptives through health workers and self-injection (Burkina Faso, Uganda, Senegal)

We conducted four cross-sectional microcosting studies in three countries (Burkina Faso, Senegal and Uganda) from December 2015 to January 2017. This data set includes primary data collected from health facilities on the resources used for injectable ...
PATH
core   +1 more source

Morbidity and Mortality Weekly Report (MMWR)

U.S. Selected Practice Rec.for Contraceptive Use (U.S. SPR), adapted by CDC from global guidance developed by the World Health Organization (WHO), provides evidence-based guidance on contraceptive use for U.S. health care providers (1).

core